- Home
- HALO vs GTLS Comparison
HALO vs GTLS Comparison
Compare HALO & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | GTLS |
|---|---|---|
| Founded | 1998 | 1859 |
| Country | United States | United States |
| Employees | N/A | 11777 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.0B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | HALO | GTLS |
|---|---|---|
| Price | $71.61 | $207.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 8 |
| Target Price | $78.64 | ★ $205.67 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | $14.31 |
| Revenue Next Year | $12.56 | $5.89 |
| P/E Ratio | ★ $58.69 | $240.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.06 | $141.47 |
| 52 Week High | $82.22 | $208.77 |
Technical Indicators
Market Signals| Indicator | HALO | GTLS |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 46.70 |
| Support Level | $67.94 | $206.59 |
| Resistance Level | $74.58 | $207.59 |
| Average True Range (ATR) | 2.03 | 0.55 |
| MACD | 0.27 | -0.03 |
| Stochastic Oscillator | 86.63 | 26.87 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.